Abstract:Zhaosheng Jiang, 1, &ast Jiahao Wang, 2, &ast Wei Meng, 1, &ast Youlang Zhou, 3 Limin Ma, 1 Yangbo Guan 1 1 Department of Urology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, People's Republic of China; 2 Department of Urology, Wuxi Hospital Affiliated to the Nanjing University of Chinese Medicine, Wuxi, People's Republic of China; 3 Research Central of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yangbo Guan; Limin Ma, Tel +86 18912888908 ; Tel +86 13404292020, Email ; Introduction: Ureteral stricture caused by iatrogenic ureteral injury induced ureteral injury is more common and challenging to recover quickly. The effective prevention of ureteral stricture due to iatrogenic ureteral injury-induced ureteral damage is a current challenge for urologists. The purpose of this study was to evaluate the effectiveness of nanoparticle/pirfenidone complex-coated ureteral stents with slow-release pirfenidone for the prevention of ureteral stricture in rabbits. In this study, we developed a nanoparticle/pirfenidone complex-coated ureteral stent to deliver pirfenidone into the injured ureter to inhibit ureteral stricture. Methods: Twelve New Zealand rabbits were divided into four groups: Sham, US, US+ Unmodified ureteral stent, and US+NP/PFD ureteral stent; we constructed an irreversible electroporation model of ureteral injury in rabbits and placed unmodified ureteral stents and nanoparticle/pirfenidone complex-coated ureteral stents into the ureter. Two weeks later, we euthanized the rabbits and removed their bilateral kidneys and ureters. We evaluated the effect of ureteral stent prophylaxis by gross specimen observation, section staining, and Western Blot. Results: We found that the nanoparticle/pirfenidone complexes could adhere uniformly to the surface of the ureteral stent. After placement into the ureter, the nanoparticle/pirfenidone complexes were able to remain on the surface of the ureteral stent. We found nanoparticle/pirfenidone complexes could diffuse in the ureteral epithelial tissue two weeks after the order. The study showed that nanoparticle/pirfenidone complex-coated ureteral stents placed into the ureter showed significantly less stenosis due to fibrosis than in US control rabbits and rabbits treated with unmodified ureteral stents. Conclusion: We used a novel platform based on nanoparticle/pirfenidone complex-coated ureteral stents for local and sustained delivery of pirfenidone, which can effectively deliver pirfenidone to the tissue and can slowly control the release of pirfenidone. Therefore, combining ureteral stents with nanoparticle/pirfenidone complexes was an effective measure to prevent ureteral stricture. Keywords: nanoparticles, ureteral stricture, fibrosis, ureteral stents, pirfenidone Ureteral stricture is defined as functional obstruction due to ureteral stricture caused by various causes such as iatrogenic ureteral injury, stones, malignancy, inflammation, fibrosis, ischemia, and trauma. 1,2 In recent years, concomitant iatrogenic ureteral injury has been growing with the increasing use of Ureteroscopy techniques. The probability of medically induced ureteral injury is reported to be 60%-94% in China and abroad. 3,4 In particular, there is an increased rate of medically induced ureteral strictures due to the use of ureteroscopy for upper urinary tract stones. 5 Therefore, how to prevent ureteral strictures caused by iatrogenic ureteral injury, especially after ureteroscopic operations, is an urgent problem for urologists today. Ureteral injury repair is usually a fibrous scar repair, characterized pathologically by massive fibroblast proliferation and excessive deposition of collagen and proteoglycans in the extracellular matrix, resulting in a disorganized collagen fiber arrangement. Studies have shown that TGF-β1 was highly expressed in fibroblasts and was the most closely related cytokine involved in scar production. 6,7 In this study, we attempted to further explore the mechanism of ureteral stricture by using an animal ureteral injury model to simulate the damage caused by medical endoscopic ureteral manipulation. Currently, the leading animal models of ureteral injury at home and abroad are the unilateral ureteral complete obstruction method and the electrocoagulation injury ureter method. 8 Therefore we attempted to explore the mechanism of ureteral stricture further using a model of ureteral injury in rabbits that more closely resembl -Abstract Truncated-

In vitro and in vivo assessment of a bilayered degradable rapamycin-eluting stent for ureteral stricture caused by holmium: YAG laser lithotripsy

Antistricture Ureteral Stents with a Braided Composite Structure and Surface Modification with Antistenosis Drugs

Abstract No. 437 Rapamycin-eluting Polymeric Stents for Biomedical Applications

Biodegradable Stent with mTOR Inhibitor-Eluting Reduces Progression of Ureteral Stricture

Biodegradable Rapamycin-Eluting Nano-Fiber Membrane-Covered Metal Stent Placement to Reduce Fibroblast Proliferation in Experimental Stricture in a Canine Model

The Effects and Mechanisms of the Rapamycin-eluting Stent in Urethral Stricture Prevention in Rabbits

Gradiently Degraded Electrospun Polyester Scaffolds with Cytostatic for Urothelial Carcinoma Therapy.

Dual-layer Drug Release System Based on Ureteral Stents Inhibits the Formation of Ureteral Stricture

A new hydrophilic biodegradable ureteral stent restrain encrustation both in vitro and in vivo

Inhibition of Ureteral Stricture by Pirfenidone-Loaded Nanoparticle-Coated Ureteral Stents with Slow-Release Pirfenidone

Preparation of Polycaprolactone/poly (lactic Acid-Glycolic Acid) Biodegradable Nano-Structure Ureteral Stent and Its Degradation Assay in Vitro

REDV/Rapamycin-loaded Polymer Combinations As a Coordinated Strategy to Enhance Endothelial Cells Selectivity for a Stent System.

Biodegradable drug-eluting urethral stent in limiting urethral stricture formation after urethral injury: An experimental study in rabbit

In Vitro and in Vivo Degradation of Rapamycin-Eluting Mg-Nd-Zn-Zr Alloy Stents in Porcine Coronary Arteries.

In vitro and in vivo studies on bacteria and encrustation resistance of heparin/poly-L-lysine-Cu nanoparticles coating mediated by PDA for ureteral stent application

Immersed multilayer biodegradable ureteral stent with reformed biodegradation: An in vitro experiment.

Introduction to Biodegradable Polylactic Acid Ureteral Stent Application for Treatment of Ureteral War Injury

Application of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: in Vitro and in Vivo Study.

Hybrid Electrospun Rapamycin-Loaded Small-Diameter Decellularized Vascular Grafts Effectively Inhibit Intimal Hyperplasia

A modified biodegradable mesh ureteral stent for treating ureteral stricture disease

[Long-term efficacy evaluation of coated metal stent implantation for ureteroscopic lithotripsy related refractory ureteral stricture].